首页 | 官方网站   微博 | 高级检索  
     

血浆炎性趋化因子CCL-2/MCP-1水平与造血干细胞移植后aGVHD及特发性肺炎综合症相关性研究
引用本文:欧阳敏,任汉云,尹明,邱志祥,岑溪南,王莉红,欧晋平,王文生,王茫桔,李渊,石永进.血浆炎性趋化因子CCL-2/MCP-1水平与造血干细胞移植后aGVHD及特发性肺炎综合症相关性研究[J].中国实验血液学杂志,2008,16(4):838-842.
作者姓名:欧阳敏  任汉云  尹明  邱志祥  岑溪南  王莉红  欧晋平  王文生  王茫桔  李渊  石永进
作者单位:北京大学第一医院血液科,北京100034
摘    要:本研究探讨CCL-2/MCP-1血浆水平在异基因造血干细胞移植前后的变化,以了解该趋化因子在急性移植物抗宿主病(aGVHD)和特发性肺炎综合症(IPS)发生、发展中的作用。选择22例异基因造血干细胞移植病例为研究对象,其中无/度aGVHD14例,Ⅱ-Ⅳ度aGVHD8例,在22例中8例临床诊断为IPS。采用固相双抗体夹心酶联免疫吸附方法每周测定血浆CCL-2/MCP-1水平并分析造血干细胞移植前、aGVHD高峰时、aGVHD控制后或进展时(Ⅲ-Ⅳ度者)CCL-2/MCP-1水平与aGVHD之间的关系,同时分析移植过程中CCL-2/MCP-1动态变化和IPS的关系。结果表明,Ⅱ-Ⅳ度aGVHD高峰时血浆CCL-2/MCP-1水平较移植前明显升高(p〈0.05),aGVHD被控制时CCL-2/MCP-1水平下降至移植前水平(p〈0.05),病情进展时CCL-2/MCP-1持续升高(P〈0.05)。发生aGVHD和/或IPS的患者CCL-2/MCP-1水平明显高于既无(或轻度)aGVHD又无IPS的患者(p=0.001)。临床诊断为IPS的患者。在移植过程中CCL-2/MCP-1水平明显升高(P=0.006)。结论:CCL-2/MCP-1血浆水平与aGVHD的发生有一定的相关性,但与IPS的发生明显相关,表明CCL-2/MCP-1在aGVHD及IPS发生中发挥作用。

关 键 词:急性移植物抗宿主病  特发性肺炎综合症  炎性趋化因子  CCL-2/MCP-1

Correlation of Chemokine CCL-2/MCP-1 Level in the Plasma with aGVHD and Idiophathic Pneumonia Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
Min Ouyang,Han-Yun Ren,Yue Yin,Zhi-Xiang Qiu,Xi-Nan Cen,Li-Hong Wang,Jin-Ping Ou,Wen-Sheng Wang,Mang-Ju Wang,Yuan Li,Yong-Jin Shi.Correlation of Chemokine CCL-2/MCP-1 Level in the Plasma with aGVHD and Idiophathic Pneumonia Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation[J].Journal of Experimental Hematology,2008,16(4):838-842.
Authors:Min Ouyang  Han-Yun Ren  Yue Yin  Zhi-Xiang Qiu  Xi-Nan Cen  Li-Hong Wang  Jin-Ping Ou  Wen-Sheng Wang  Mang-Ju Wang  Yuan Li  Yong-Jin Shi
Affiliation:Department of Hematology, Peking University First Hospital, Beijing 100034, China.
Abstract:The aim of this study was to investigate the relationship between the plasma levels of chemokine CCL-2/MCP-1 and acute graft-versus-host disease (aGVHD) and/or idiopathic pneumonia syndrome (IPS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). ELISA assays were used to detect the plasma level of CCL-2/MCP-1 of 22 patients who received allo-HSCT, including 14 patients without or with grade I, 8 patients with grade II - IV aGVHD, respectively. 8 out of 22 patients were also diagnosed with IPS clinically. The dynamic changes of the plasma levels of CCL-2/MCP-1 chemokine and its correlation with aGVHD and/or IPS were analysized retrospectively. The results showed that the plasma levels of CCL-2/MCP-1 in the patients with moderate and serious aGVHD (grade II - IV) significantly increased, as compared with that prior to allo-HSCT (p < 0.05). The plasma levels of CCL-2/MCP-1 in the patients with aGVHD and/or IPS were higher significantly than those without any of these complications (p = 0.001). The retrospective analysis indicated that the plasma levels of CCL-2/MCP-1 in the patients with IPS significantly increased (p = 0.006). It is concluded that plasma level of CCL-2/MCP-1 correlates with aGVHD and/or IPS, and plays a role in the pathogenesis of these complications.
Keywords:acute graft-versus-host disease  idiopathic pneumonia syndrome  chemokine  CCL-2/MCP-1
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号